Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Life threatening ventricular arrhythmias with transient or correctable causes.

G D Veenhuyzen1, D G Wyse

  • 1Division of Cardiology, Department of Cardiac Sciences, University of Calgary & Calgary Health Region, Calgary, Alberta, Canada.

Minerva Cardioangiologica
|July 18, 2003
PubMed
Summary

Life-threatening ventricular tachyarrhythmias from myocardial ischemia, electrolyte issues, or drug reactions may not be reversible. Physicians must exercise caution when attributing these arrhythmias to these causes, as outcomes are often poor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials.

Journal of cardiovascular electrophysiology·2014
Same author

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.

Lancet (London, England)·2008
Same author

Rate control versus rhythm control--decision making.

The Canadian journal of cardiology·2005
Same author

Management of atrial fibrillation.

Current problems in cardiology·2005
Same author

Ethical issues with implantable defibrillators.

Pacing and clinical electrophysiology : PACE·2005
Same author

International consensus on nomenclature and classification of atrial fibrillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2003

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • Ventricular tachyarrhythmias (VT/VF) are often attributed to transient causes like ischemia, electrolyte disorders, and drug reactions.
  • Emerging evidence indicates a poor prognosis for patients with VT/VF linked to these factors.
  • This review examines the literature on these conditions as potentially reversible causes of VT/VF.

Purpose of the Study:

  • To review the literature on myocardial ischemia, electrolyte disorders, and proarrhythmic drug reactions as causes of ventricular tachycardia and fibrillation.
  • To assess the evidence for the reversibility of these conditions in the context of life-threatening tachyarrhythmias.
  • To guide clinical attention and caution regarding these potential triggers.

Main Methods:

Related Experiment Videos

  • Comprehensive literature review of studies investigating ischemia, electrolyte imbalances, and drug-induced arrhythmias.
  • Analysis of evidence regarding the identification and reversal of these factors in patients with VT/VF.
  • Synthesis of findings to evaluate their role in the genesis and prognosis of ventricular tachyarrhythmias.

    • Main Results:

    • Proarrhythmic drug reactions show potential as reversible causes of VT/VF.
    • Hypokalemia and hypomagnesemia are identified as significant risk factors for VT/VF.
    • The role of myocardial ischemia in VT/VF genesis is complex and not always reversible.
    • Difficulties exist in identifying and reversing the influence of these factors.

    Conclusions:

    • Physicians should be extremely cautious when attributing life-threatening ventricular tachyarrhythmias to ischemia, electrolyte disorders, or drug reactions.
    • These conditions, while involved in arrhythmia genesis, may not be truly reversible, impacting patient outcomes.
    • Further research is necessary to identify definitively reversible causes of VT/VF.